…
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 12.36M | -57.61M | -206.58M | -232.73M | -333.11M |
| Net income | 9.66M | -57.44M | -186.26M | -215.56M | -307.20M |
| Selling general administrative | 382.20M | 363.06M | 410.79M | 377.99M | 433.73M |
| Selling and marketing expenses | - | - | 1.79M | - | - |
| Gross profit | 461.10M | 402.40M | 302.10M | 237.02M | 201.51M |
| Reconciled depreciation | 54.75M | 70.95M | 77.11M | 69.20M | 54.14M |
| Ebit | 24.02M | -31.08M | -185.36M | -210.17M | -286.35M |
| Ebitda | 78.78M | 39.87M | -104.93M | -141.19M | -233.69M |
| Depreciation and amortization | 54.75M | 70.95M | 80.44M | 68.98M | 52.67M |
| Non operating income net other | - | - | - | -2.63M | -7.84M |
| Operating income | 24.15M | -31.61M | -189.13M | -210.17M | -286.35M |
| Other operating expenses | 1400.14M | 1282.58M | 1244.80M | 1069.72M | 953.86M |
| Interest expense | 11.66M | 26.54M | 21.22M | 19.93M | 38.91M |
| Tax provision | 2.70M | -0.17M | -34.02M | -17.17M | -25.91M |
| Net interest income | -11.66M | -26.54M | -20.85M | -19.93M | -38.91M |
| Income tax expense | 2.70M | -0.17M | -20.32M | -17.17M | -25.91M |
| Total revenue | 1424.29M | 1250.97M | 1055.66M | 859.54M | 667.51M |
| Total operating expenses | 436.95M | 434.01M | 491.23M | 447.19M | 487.86M |
| Cost of revenue | 963.19M | 848.57M | 753.57M | 622.52M | 466.00M |
| Total other income expense net | -11.79M | -26.00M | -17.45M | -22.56M | -46.75M |
| Net income from continuing ops | 9.66M | -57.44M | -187.96M | -215.56M | -307.20M |
| Net income applicable to common shares | - | - | - | -215.56M | -343.95M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 2203.93M | 2118.30M | 2233.21M | 2173.87M | 1927.11M |
| Intangible assets | 177.66M | 190.80M | 221.07M | 263.29M | 300.36M |
| Other current assets | 71.85M | 25.91M | 21.27M | 23.73M | 4.34M |
| Total liab | 682.92M | 672.01M | 804.28M | 655.15M | 382.08M |
| Total stockholder equity | 1521.02M | 1446.29M | 1428.93M | 1518.72M | 1545.03M |
| Deferred long term liab | - | - | - | 38.70M | 54.28M |
| Other current liab | 200.30M | 164.94M | 146.42M | 124.89M | 16.09M |
| Common stock | 3.88M | 3.83M | 3.79M | 3.76M | 3.74M |
| Capital stock | 3.88M | 3.83M | 3.79M | 3.76M | 3.74M |
| Retained earnings | -808.63M | -818.29M | -760.85M | -572.64M | -357.07M |
| Other liab | - | - | - | 41.48M | 107.91M |
| Good will | 1293.35M | 1293.35M | 1293.35M | 1272.94M | 1204.54M |
| Other assets | - | - | - | 6.37M | 3.45M |
| Cash | 248.64M | 154.57M | 78.82M | 108.62M | 148.03M |
| Total current liabilities | 251.96M | 228.89M | 202.87M | 176.00M | 116.75M |
| Current deferred revenue | - | - | - | - | 85.19M |
| Net debt | -54.55M | 330.62M | 432.22M | 367.87M | 9.39M |
| Short term debt | 45.54M | 56.70M | 49.40M | 38.82M | 1.32M |
| Short long term debt | 14.50M | 7.25M | - | 2.35M | 1.32M |
| Short long term debt total | 194.10M | 485.19M | 511.04M | 476.49M | 157.42M |
| Other stockholder equity | 2325.76M | 2259.82M | 2183.68M | 2084.32M | 1898.36M |
| Property plant equipment | - | - | - | 194.19M | 152.24M |
| Total current assets | 416.20M | 312.51M | 225.73M | 233.22M | 266.52M |
| Net tangible assets | - | - | - | -17.51M | 40.13M |
| Net receivables | 95.71M | 132.03M | 125.64M | 100.87M | 76.08M |
| Long term debt | 265.93M | 279.79M | 280.29M | 225.08M | 157.42M |
| Inventory | - | - | 0.00M | - | 38.07M |
| Accounts payable | 6.12M | 7.24M | 7.05M | 12.29M | 14.15M |
| Accumulated other comprehensive income | - | 0.93M | 2.30M | 3.27M | - |
| Common stock total equity | - | - | - | 3.76M | 3.74M |
| Retained earnings total equity | - | - | - | -572.64M | -357.07M |
| Non currrent assets other | 5.42M | 7.72M | 7.96M | 10.79M | 3.45M |
| Non current assets total | 1787.73M | 1805.79M | 2007.48M | 1940.65M | 1660.59M |
| Capital lease obligations | 194.10M | 198.15M | 227.83M | 251.41M | - |
| Long term debt total | - | - | - | 225.08M | 157.42M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -21.57M | -79.22M | -139.46M | -194.08M |
| Change to liabilities | - | - | - | 21.32M | 0.62M |
| Total cashflows from investing activities | -36.12M | -21.57M | -60.34M | -139.46M | -194.08M |
| Net borrowings | -7.25M | -1.69M | 55.28M | 60.68M | -212.59M |
| Total cash from financing activities | -15.96M | -9.95M | 47.43M | 47.26M | 313.86M |
| Change to operating activities | - | - | - | -2.94M | 25.73M |
| Net income | 9.66M | -57.44M | -186.26M | -215.56M | -307.20M |
| Change in cash | 94.07M | 75.75M | -29.80M | -39.41M | 129.20M |
| Begin period cash flow | 154.57M | 78.82M | 108.62M | 148.03M | 18.83M |
| End period cash flow | 248.64M | 154.57M | 78.82M | 108.62M | 148.03M |
| Total cash from operating activities | 146.15M | 107.26M | -16.88M | 52.79M | 9.42M |
| Issuance of capital stock | - | - | 0.00M | 0.00M | 549.90M |
| Depreciation | 54.75M | 70.95M | 80.44M | 69.20M | 54.14M |
| Other cashflows from investing activities | -36.12M | -21.57M | - | -60.21M | -99.58M |
| Change to account receivables | 36.09M | -6.40M | -24.18M | -21.66M | -24.21M |
| Sale purchase of stock | - | - | - | 0.00M | 549.90M |
| Other cashflows from financing activities | -8.71M | -8.26M | -7.86M | 235.03M | 75.34M |
| Change to netincome | - | - | - | 191.03M | 258.54M |
| Capital expenditures | 36.12M | 21.57M | 40.52M | 79.25M | 94.49M |
| Change receivables | - | - | - | -21.66M | -24.21M |
| Cash flows other operating | - | - | - | 6.52M | -44.46M |
| Cash and cash equivalents changes | - | - | - | -39.41M | 129.20M |
| Change in working capital | -40.34M | -27.37M | -33.72M | -16.94M | 2.14M |
| Stock based compensation | 74.70M | 76.17M | 99.39M | 187.43M | 259.44M |
| Other non cash items | 44.96M | 45.91M | 45.20M | 45.40M | 27.85M |
| Free cash flow | 110.03M | 85.69M | -57.40M | -26.47M | -85.07M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| LFST Lifestance Health Group Inc |
0.18 1.31% |
13.95 | 100.46 | 58.14 | 3.13 | 3.44 | 3.36 | 40.42 |
| HCA HCA Healthcare, Inc. |
8.00 1.62% |
502.99 | 14.27 | 13.46 | 1.21 | 291.34 | 1.83 | 8.99 |
| THC Tenet Healthcare Corporation |
5.54 1.95% |
288.87 | 10.08 | 12.66 | 0.96 | 4.57 | 1.43 | 5.80 |
| FSNUY Fresenius SE & Co KGaA ADR |
0.27 1.86% |
14.79 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| JDHIY JD Health International Inc |
0.29 5.59% |
5.57 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.
4800 North Scottsdale Road, Scottsdale, AZ, United States, 85251
602 767 2100
8542
| Name | Title | Year Born |
|---|---|---|
| Mr. Kenneth Alan Burdick | CEO & Chairman | 1959 |
| Mr. Danish J. Qureshi | Pres & COO | 1984 |
| Mr. David Patrick Bourdon | Chief Financial Officer & Treasurer | 1969 |
| Mr. Warren Gouk | Chief Admin. Officer | NA |
| Ms. Monica Prokocki | VP of Investor Relations | NA |
| Mr. Ryan Pardo | Chief Legal Officer & Sec. | 1976 |
| Brooke Matthews | Director of PR | NA |
| Ms. Felicia Gorcyca | Chief People Officer | 1979 |
| Mr. Pablo Pantaleoni | Chief Digital Officer | 1988 |
| Mr. Kevin Michael Mullins | Chief Devel. Officer | 1985 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.